TrPharma by Dr. Ashwani Dhar
TrPharma is a doctor-led pharmaceutical division of ThinkRoman Ventures LLP, founded by Dr. Ashwani Dhar, MD, DMI.
Combining clinical expertise with pharmaceutical innovation, TrPharma delivers high-quality, affordable medications. Our flagship product KashMOX 625 exemplifies our commitment to accessible healthcare.
TrPharma
A Division of ThinkRoman Ventures LLP
KashMOX 625 - Guard Your Health
KashMOX 625(Amoxicillin 500mg + Potassium Clavulanate 125mg) is TrPharma's flagship broad-spectrum antibiotic, designed for effective treatment of bacterial infections.
Amoxicillin & Potassium Clavulanate Tablets I.P.
KashMOX 625 combines the power of Amoxicillin with Clavulanic Acid to tackle infections head-on. The Clavulanic Acid component overcomes bacterial resistance by inhibiting beta-lactamase enzymes, making KashMOX effective against a wider range of bacteria.
Composition
- Amoxicillin Trihydrate I.P. eq. to Amoxicillin - 500 mg
- Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid - 125 mg
Indications
Broad-Spectrum Coverage
Effective against gram-positive and gram-negative bacteria including beta-lactamase producers
Fast Acting
Quick absorption and rapid onset of action for faster symptom relief
GMP Certified
Manufactured in WHO-GMP certified facilities ensuring highest quality standards
Well Tolerated
Clavulanic acid enhances efficacy while maintaining excellent safety profile
The Doctor-Led Advantage
TrPharma is uniquely positioned at the intersection of clinical medicine and pharmaceutical innovation, led by a physician who understands both patient needs and healthcare delivery.
Doctor-Led Innovation
Founded by Dr. Ashwani Dhar MD DMI, former CMIO at Cerner/Oracle Health, bringing clinical expertise to pharmaceutical development.
Quality Assured
All products manufactured in WHO-GMP certified facilities with rigorous quality control protocols.
Patient-First Approach
Committed to making quality healthcare accessible and affordable for all patients.
Part of ThinkRoman
Backed by ThinkRoman Ventures LLP, a healthcare innovation ecosystem with 20+ initiatives.
Dr. Ashwani Dhar, MD, DMI
Founder & CEO, TrPharma | CEO, ThinkRoman Ventures
Dr. Ashwani Dhar brings decades of clinical and healthcare technology experience to TrPharma. As a former Senior Physician Executive and CMIO at Cerner/Oracle Health, and with an MD and Doctor of Medical Informatics (DMI), he leads TrPharma with a unique blend of medical expertise and innovation.
Discover All TrPharma Products
Beyond KashMOX 625, TrPharma offers a comprehensive range of high-quality, affordable medications including antibiotics, pain relief, and specialty drugs.